ALBUMIN HUMAN

ALBUMIN HUMAN was reported 2402 times

ALBUMIN HUMAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACCESSORY MUSCLE 2 0.6667
1 CORTICAL VISUAL IMPAIRMENT 3 0.1500
2 MULTISYSTEM INFLAMMATORY SYNDROME 4 0.1333
3 KIDNEY MALROTATION 4 0.1333
4 IMPETIGO HERPETIFORMIS 3 0.1250
5 ADRENAL CORTICAL INSUFFICIENCY 2 0.0625
6 CYTOMEGALOVIRUS TEST 2 0.0465
7 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 16 0.0394
8 BRASH SYNDROME 6 0.0353
9 HEPARIN-INDUCED THROMBOCYTOPENIA TEST 2 0.0328
10 BLOOD CORTICOTROPHIN ABNORMAL 2 0.0312
11 TRANSFUSION-RELATED ACUTE LUNG INJURY 6 0.0303
12 POSTOPERATIVE RENAL FAILURE 4 0.0299
13 HAPTOGLOBIN ABNORMAL 2 0.0278
14 BURKHOLDERIA TEST POSITIVE 3 0.0259
15 HEPATIC VEIN OCCLUSION 3 0.0229
16 ACQUIRED EPIDERMOLYSIS BULLOSA 2 0.0225
17 FAILURE TO ANASTOMOSE 2 0.0217
18 INCISION SITE CELLULITIS 2 0.0211
19 TRI-IODOTHYRONINE FREE DECREASED 4 0.0207
20 MORGANELLA INFECTION 4 0.0175
21 HAEMORRHAGIC ASCITES 4 0.0172
22 RED BLOOD CELL SCHISTOCYTES PRESENT 5 0.0172
23 GALLOP RHYTHM PRESENT 2 0.0169
24 HEPATITIS C POSITIVE 2 0.0164
25 REFRACTORY ANAEMIA 3 0.0163
26 BONE MARROW INFILTRATION 4 0.0160
27 DELAYED GRAFT FUNCTION 7 0.0140
28 CANDIDA PNEUMONIA 3 0.0133
29 B-CELL TYPE ACUTE LEUKAEMIA 2 0.0130
30 ASPERGILLUS TEST POSITIVE 3 0.0124
31 HYPOPROTEINAEMIA 16 0.0123
32 LASER THERAPY 2 0.0108
33 LUNG INFECTION PSEUDOMONAL 6 0.0107
34 HYPOALBUMINAEMIA 56 0.0103
35 MULTI-ORGAN FAILURE 173 0.0100
36 TRICHOSPORON INFECTION 3 0.0097
37 FEAR 219 0.0093
38 TUMOUR FLARE 4 0.0088
39 COUNTERFEIT DRUG ADMINISTERED 3 0.0087
40 CIRRHOSIS ALCOHOLIC 3 0.0083
41 LOWER RESPIRATORY TRACT INFECTION FUNGAL 3 0.0082
42 HEPATIC ISCHAEMIA 2 0.0082
43 CULTURE STOOL POSITIVE 2 0.0081
44 OCULOMUCOCUTANEOUS SYNDROME 3 0.0081
45 STENOTROPHOMONAS INFECTION 7 0.0080
46 ENDOCARDITIS BACTERIAL 5 0.0080
47 HEPATIC VEIN THROMBOSIS 2 0.0078
48 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 2 0.0078
49 FEAR OF DEATH 13 0.0077
50 SEPTIC EMBOLUS 5 0.0076
51 SUBCUTANEOUS EMPHYSEMA 5 0.0073
52 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0072
53 AMMONIA ABNORMAL 2 0.0072
54 ADENOMA BENIGN 5 0.0072
55 RENAL INJURY 194 0.0071
56 URINARY TRACT INFECTION FUNGAL 3 0.0070
57 ANHEDONIA 155 0.0069
58 SPUTUM CULTURE POSITIVE 5 0.0069
59 LIP EROSION 4 0.0068
60 CAECITIS 3 0.0067
61 FEEDING TUBE COMPLICATION 2 0.0064
62 ZYGOMYCOSIS 3 0.0064
63 SURGICAL PROCEDURE REPEATED 4 0.0064
64 HILAR LYMPHADENOPATHY 4 0.0063
65 GLIOSIS 2 0.0063
66 ACINETOBACTER INFECTION 5 0.0063
67 ABDOMINAL SEPSIS 4 0.0062
68 PUPILLARY REFLEX IMPAIRED 9 0.0062
69 SLOW RESPONSE TO STIMULI 6 0.0061
70 RESPIRATORY TRACT HAEMORRHAGE 3 0.0061
71 ASPERGILLOSIS 8 0.0061
72 CORONARY ARTERY INSUFFICIENCY 2 0.0061
73 ENTEROCOCCAL SEPSIS 4 0.0060
74 ENTEROCOCCUS TEST POSITIVE 3 0.0060
75 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0059
76 COMA HEPATIC 4 0.0059
77 ANAEMIA VITAMIN B12 DEFICIENCY 2 0.0058
78 DUODENAL PERFORATION 4 0.0058
79 DELAYED RECOVERY FROM ANAESTHESIA 4 0.0056
80 OEDEMA GENITAL 3 0.0056
81 ENCEPHALITIS HERPES 2 0.0056
82 PNEUMONIA KLEBSIELLA 7 0.0056
83 BLOOD URIC ACID DECREASED 2 0.0055
84 KLEBSIELLA INFECTION 19 0.0055
85 CENTRAL LINE INFECTION 2 0.0054
86 PSEUDOMEMBRANOUS COLITIS 10 0.0053
87 CYTOKINE STORM 2 0.0052
88 HEPATIC NEOPLASM MALIGNANT 11 0.0052
89 ENGRAFTMENT SYNDROME 2 0.0052
90 PNEUMONIA FUNGAL 12 0.0052
91 SYSTEMIC MYCOSIS 4 0.0051
92 HYPOPERFUSION 4 0.0051
93 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 5 0.0050
94 LIVEDO RETICULARIS 8 0.0050
95 CYTOKINE RELEASE SYNDROME 28 0.0049
96 HEPARIN-INDUCED THROMBOCYTOPENIA 19 0.0048
97 FUSARIUM INFECTION 2 0.0047
98 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 10 0.0047
99 KIDNEY ENLARGEMENT 4 0.0046
100 PNEUMATOSIS INTESTINALIS 9 0.0046
101 BILIARY TRACT INFECTION 2 0.0046
102 PNEUMONIA STAPHYLOCOCCAL 7 0.0045
103 INJURY 268 0.0045
104 OLIGURIA 22 0.0045
105 HEPATORENAL SYNDROME 6 0.0043
106 CAPILLARY LEAK SYNDROME 6 0.0043
107 ABDOMINAL COMPARTMENT SYNDROME 2 0.0043
108 CONTINUOUS HAEMODIAFILTRATION 4 0.0042
109 INCISION SITE PAIN 4 0.0042
110 LIVER TRANSPLANT REJECTION 6 0.0041
111 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0041
112 MUCOSAL EROSION 3 0.0041
113 UNEVALUABLE EVENT 248 0.0041
114 DISSEMINATED INTRAVASCULAR COAGULATION 47 0.0041
115 ISCHAEMIC HEPATITIS 4 0.0040
116 ALANINE AMINOTRANSFERASE DECREASED 2 0.0040
117 GENERALISED OEDEMA 36 0.0040
118 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 17 0.0039
119 CHRONIC HEPATIC FAILURE 2 0.0039
120 MECHANICAL VENTILATION 6 0.0039
121 PROCEDURAL HYPOTENSION 3 0.0039
122 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 4 0.0038
123 SYSTEMIC CANDIDA 6 0.0038
124 HYPERVOLAEMIA 5 0.0038
125 HYPERLEUKOCYTOSIS 2 0.0038
126 RED BLOOD CELLS URINE POSITIVE 3 0.0037
127 STAPHYLOCOCCAL SEPSIS 15 0.0037
128 HAEMODYNAMIC INSTABILITY 19 0.0037
129 BLOOD CULTURE POSITIVE 10 0.0037
130 RENAL IMPAIRMENT 221 0.0037
131 ASCITES 82 0.0036
132 HEPATITIS C VIRUS 2 0.0035
133 STAPHYLOCOCCUS TEST POSITIVE 6 0.0035
134 LARGE INTESTINAL ULCER 7 0.0035
135 VENOOCCLUSIVE LIVER DISEASE 12 0.0034
136 CYTOMEGALOVIRUS VIRAEMIA 9 0.0034
137 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0034
138 STRESS 173 0.0034
139 STAPHYLOCOCCAL BACTERAEMIA 10 0.0033
140 GRAFT VERSUS HOST DISEASE 19 0.0033
141 ORGAN FAILURE 11 0.0033
142 BRAIN CONTUSION 2 0.0033
143 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0033
144 STEM CELL TRANSPLANT 6 0.0033
145 RENAL FAILURE 362 0.0032
146 HYPERURICAEMIA 10 0.0032
147 CULTURE URINE POSITIVE 4 0.0032
148 ADENOVIRUS INFECTION 6 0.0032
149 AORTIC VALVE SCLEROSIS 2 0.0032
150 OSTEOSCLEROSIS 4 0.0032
151 BRONCHOPULMONARY DYSPLASIA 2 0.0031
152 NEPHROTIC SYNDROME 16 0.0031
153 ANOXIC ENCEPHALOPATHY 2 0.0031
154 BLOOD UREA INCREASED 44 0.0031
155 SKIN INDURATION 5 0.0031
156 INTRA-ABDOMINAL HAEMORRHAGE 6 0.0031
157 NEUROLOGICAL SYMPTOM 13 0.0031
158 HEART SOUNDS ABNORMAL 2 0.0031
159 CEREBRAL VENTRICLE DILATATION 3 0.0031
160 RENAL FAILURE ACUTE 130 0.0031
161 PSEUDOMONAL SEPSIS 4 0.0031
162 KIDNEY TRANSPLANT REJECTION 12 0.0030
163 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0030
164 HYPERNATRAEMIA 11 0.0030
165 ENTEROCUTANEOUS FISTULA 2 0.0030
166 FUNGAL SEPSIS 2 0.0030
167 EXTREMITY NECROSIS 4 0.0030
168 BLADDER CATHETERISATION 2 0.0029
169 BLOOD ALBUMIN INCREASED 2 0.0029
170 INFECTIOUS PERITONITIS 2 0.0029
171 ADRENAL SUPPRESSION 2 0.0029
172 BLOOD FIBRINOGEN INCREASED 2 0.0029
173 LYMPHADENOPATHY MEDIASTINAL 4 0.0029
174 PERITONEAL HAEMORRHAGE 4 0.0029
175 ENTEROCOCCAL BACTERAEMIA 2 0.0029
176 BACTERIAL SEPSIS 7 0.0028
177 BLOOD MAGNESIUM INCREASED 2 0.0028
178 IMMUNE-MEDIATED ADVERSE REACTION 2 0.0028
179 CARDIOPULMONARY FAILURE 9 0.0028
180 HODGKIN'S DISEASE 2 0.0028
181 TOXIC ENCEPHALOPATHY 9 0.0027
182 BILIRUBIN CONJUGATED INCREASED 5 0.0027
183 OPPORTUNISTIC INFECTION 4 0.0027
184 EXTRADURAL HAEMATOMA 3 0.0027
185 CATHETER RELATED COMPLICATION 3 0.0027
186 ESCHERICHIA SEPSIS 6 0.0027
187 NEONATAL DISORDER 4 0.0026
188 HYPERBILIRUBINAEMIA 20 0.0026
189 ANAEMIA OF CHRONIC DISEASE 2 0.0026
190 CYTOGENETIC ANALYSIS ABNORMAL 2 0.0026
191 SKIN NECROSIS 11 0.0026
192 HAEMOTHORAX 6 0.0026
193 ACUTE PRERENAL FAILURE 3 0.0026
194 CONJUNCTIVAL OEDEMA 2 0.0026
195 BACTERAEMIA 21 0.0026
196 TOXIC EPIDERMAL NECROLYSIS 28 0.0025
197 URINE OUTPUT DECREASED 18 0.0025
198 CARBON DIOXIDE DECREASED 2 0.0025
199 MALNUTRITION 20 0.0025
200 DEVICE DAMAGE 2 0.0025
201 TROPONIN I INCREASED 3 0.0025
202 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0025
203 DUODENAL ULCER HAEMORRHAGE 6 0.0025
204 HAEMOLYTIC URAEMIC SYNDROME 5 0.0024
205 SHOCK 41 0.0024
206 SEPTIC SHOCK 75 0.0024
207 ACUTE PULMONARY OEDEMA 11 0.0024
208 CHRONIC RESPIRATORY FAILURE 2 0.0024
209 BLOOD ALBUMIN DECREASED 15 0.0024
210 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0024
211 ACIDOSIS 14 0.0023
212 BLOOD AMYLASE INCREASED 4 0.0023
213 AREFLEXIA 5 0.0023
214 BACTERIAL TEST POSITIVE 4 0.0023
215 COMPLICATIONS OF TRANSPLANTED KIDNEY 4 0.0023
216 VENA CAVA THROMBOSIS 3 0.0022
217 HYPERCAPNIA 5 0.0022
218 ENCEPHALOPATHY 40 0.0022
219 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
220 PROTHROMBIN TIME PROLONGED 12 0.0022
221 PNEUMONIA CYTOMEGALOVIRAL 3 0.0022
222 ABDOMINAL INFECTION 4 0.0022
223 VENOOCCLUSIVE DISEASE 4 0.0022
224 JOINT CONTRACTURE 2 0.0022
225 STEVENS-JOHNSON SYNDROME 40 0.0022
226 TACHYPNOEA 21 0.0022
227 AORTIC VALVE STENOSIS 3 0.0022
228 COAGULOPATHY 29 0.0022
229 HEPATIC ENCEPHALOPATHY 16 0.0022
230 BLOOD BILIRUBIN INCREASED 47 0.0022
231 CEREBRAL ATROPHY 7 0.0021
232 FIXED ERUPTION 2 0.0021
233 PARAPARESIS 3 0.0021
234 HEPATIC CONGESTION 2 0.0021
235 ACUTE RESPIRATORY FAILURE 28 0.0021
236 ANTIBODY TEST POSITIVE 3 0.0021
237 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0021
238 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0021
239 RENAL FAILURE CHRONIC 16 0.0021
240 PSYCHIATRIC SYMPTOM 12 0.0021
241 RESPIRATORY FAILURE 118 0.0021
242 PROTEIN TOTAL DECREASED 6 0.0021
243 PLEURAL EFFUSION 98 0.0021
244 ACUTE LUNG INJURY 2 0.0021
245 ENDOTRACHEAL INTUBATION 4 0.0020
246 DEVICE RELATED SEPSIS 3 0.0020
247 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0020
248 NEPHROGENIC SYSTEMIC FIBROSIS 6 0.0020
249 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0020
250 BLOOD UREA DECREASED 2 0.0020
251 CONGESTIVE CARDIOMYOPATHY 8 0.0020
252 CATHETER RELATED INFECTION 2 0.0020
253 HYPOVOLAEMIA 9 0.0020
254 VENTRICULAR HYPOKINESIA 5 0.0020
255 BK VIRUS INFECTION 4 0.0020
256 HEPATIC FAILURE 47 0.0020
257 CARDIOGENIC SHOCK 19 0.0020
258 CLOSTRIDIAL INFECTION 6 0.0019
259 COMPARTMENT SYNDROME 4 0.0019
260 TACHYARRHYTHMIA 4 0.0019
261 HYPOXIA 49 0.0019
262 PULMONARY INFARCTION 4 0.0019
263 SKIN HYPERTROPHY 4 0.0019
264 ENTEROCOLITIS 7 0.0019
265 BLOOD PH DECREASED 3 0.0019
266 PROTEIN URINE PRESENT 7 0.0019
267 CLOSTRIDIUM COLITIS 2 0.0019
268 RENAL TUBULAR NECROSIS 14 0.0019
269 ORTHOPNOEA 5 0.0019
270 FIBRIN D DIMER INCREASED 5 0.0019
271 OVARIAN HYPERSTIMULATION SYNDROME 3 0.0019
272 PERIPHERAL ISCHAEMIA 6 0.0019
273 TUMOUR LYSIS SYNDROME 11 0.0019
274 SMALL INTESTINAL HAEMORRHAGE 3 0.0018
275 WOUND DEHISCENCE 5 0.0018
276 LUNG CONSOLIDATION 4 0.0018
277 EMOTIONAL DISTRESS 194 0.0018
278 DEATH NEONATAL 2 0.0018
279 HYPERTRANSAMINASAEMIA 5 0.0018
280 APGAR SCORE LOW 2 0.0018
281 BRADYPNOEA 3 0.0018
282 FUNGAEMIA 2 0.0018
283 GANGRENE 9 0.0018
284 HEPATOCELLULAR DAMAGE 4 0.0018
285 NEUTROPHIL COUNT INCREASED 14 0.0018
286 EPSTEIN-BARR VIRUS INFECTION 8 0.0018
287 IATROGENIC INJURY 2 0.0018
288 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0018
289 BRAIN OEDEMA 17 0.0018
290 ENTEROCOCCAL INFECTION 6 0.0018
291 PULMONARY OEDEMA 60 0.0017
292 HYPOKALAEMIA 58 0.0017
293 SEPSIS 145 0.0017
294 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0017
295 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2 0.0017
296 INTESTINAL ISCHAEMIA 7 0.0017
297 CHOLANGITIS 7 0.0017
298 HEPATIC FUNCTION ABNORMAL 44 0.0017
299 FIBROSIS 4 0.0017
300 LYMPHOCYTE COUNT DECREASED 22 0.0017
301 OCCULT BLOOD POSITIVE 3 0.0017
302 ILEUS 15 0.0016
303 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0016
304 HEPATITIS B 8 0.0016
305 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0016
306 BLOOD BLISTER 4 0.0016
307 PERICARDIAL HAEMORRHAGE 3 0.0016
308 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0016
309 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0016
310 CHOLANGITIS SCLEROSING 2 0.0016
311 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0016
312 ALVEOLITIS 2 0.0016
313 VENTRICULAR FIBRILLATION 14 0.0016
314 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0016
315 RALES 7 0.0016
316 RESPIRATORY DISTRESS 34 0.0016
317 PULMONARY HAEMORRHAGE 10 0.0016
318 HYPERKALAEMIA 41 0.0016
319 SHOCK HAEMORRHAGIC 9 0.0015
320 CLOSTRIDIUM TEST POSITIVE 2 0.0015
321 RENAL TRANSPLANT 4 0.0015
322 LEUKOCYTOSIS 21 0.0015
323 CACHEXIA 6 0.0015
324 OLIGOHYDRAMNIOS 4 0.0015
325 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0015
326 AMYLASE INCREASED 4 0.0015
327 CARDIOVASCULAR INSUFFICIENCY 2 0.0015
328 HYPERPHOSPHATAEMIA 2 0.0015
329 ILEUS PARALYTIC 5 0.0015
330 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0015
331 CANDIDIASIS 6 0.0015
332 LARGE INTESTINE PERFORATION 8 0.0015
333 ACUTE LEUKAEMIA 2 0.0015
334 HEPATOMEGALY 12 0.0015
335 BLOOD CHOLESTEROL DECREASED 2 0.0015
336 MOUTH HAEMORRHAGE 8 0.0015
337 LEUKAEMIA RECURRENT 2 0.0015
338 ENTERITIS INFECTIOUS 2 0.0015
339 BRONCHOPNEUMONIA 5 0.0015
340 POLYURIA 9 0.0015
341 SUPRAVENTRICULAR TACHYCARDIA 11 0.0014
342 TORSADE DE POINTES 9 0.0014
343 HEPATOSPLENOMEGALY 3 0.0014
344 NEPHROGENIC ANAEMIA 6 0.0014
345 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0014
346 LUNG INFILTRATION 11 0.0014
347 FOETAL GROWTH RESTRICTION 6 0.0014
348 NEUROTOXICITY 16 0.0014
349 COLITIS ISCHAEMIC 7 0.0014
350 HEPATITIS C 15 0.0014
351 HAEMODIALYSIS 11 0.0014
352 HENOCH-SCHONLEIN PURPURA 2 0.0014
353 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0014
354 HYPOCALCAEMIA 19 0.0014
355 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0014
356 ASPARTATE AMINOTRANSFERASE INCREASED 57 0.0014
357 SKIN TIGHTNESS 5 0.0013
358 METABOLIC ENCEPHALOPATHY 3 0.0013
359 HAEMATOCRIT DECREASED 22 0.0013
360 HAEMORRHAGE INTRACRANIAL 17 0.0013
361 FEBRILE NEUTROPENIA 61 0.0013
362 HUMAN HERPESVIRUS 6 INFECTION 2 0.0013
363 THROMBOTIC THROMBOCYTOPENIC PURPURA 4 0.0013
364 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
365 EPIGASTRIC DISCOMFORT 4 0.0013
366 VENTRICULAR HYPERTROPHY 3 0.0013
367 LIP DISORDER 2 0.0013
368 VARICES OESOPHAGEAL 3 0.0013
369 DIALYSIS 15 0.0013
370 CYANOSIS 16 0.0013
371 ATELECTASIS 10 0.0013
372 HYPERCOAGULATION 2 0.0013
373 THROMBOTIC MICROANGIOPATHY 8 0.0013
374 DUODENITIS 3 0.0012
375 FLUID OVERLOAD 18 0.0012
376 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
377 ESCHERICHIA URINARY TRACT INFECTION 4 0.0012
378 PANCYTOPENIA 50 0.0012
379 SPLENOMEGALY 11 0.0012
380 TRANSPLANT REJECTION 7 0.0012
381 COLONIC POLYP 2 0.0012
382 HYPERPARATHYROIDISM 2 0.0012
383 CYTOLYTIC HEPATITIS 4 0.0012
384 MYOCARDIAL ISCHAEMIA 12 0.0012
385 RESPIRATORY RATE DECREASED 3 0.0012
386 PSEUDOMONAS INFECTION 7 0.0012
387 LEFT VENTRICULAR DYSFUNCTION 6 0.0012
388 WOUND COMPLICATION 3 0.0012
389 EXCORIATION 3 0.0012
390 RIGHT VENTRICULAR FAILURE 7 0.0012
391 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0012
392 FAILURE TO THRIVE 5 0.0012
393 BACTERIAL INFECTION 15 0.0012
394 DIVERTICULAR PERFORATION 2 0.0012
395 HYPOMAGNESAEMIA 11 0.0011
396 ANXIETY 255 0.0011
397 CYTOMEGALOVIRUS INFECTION 14 0.0011
398 CATHETER SITE PAIN 2 0.0011
399 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0011
400 CIRCULATORY COLLAPSE 16 0.0011
401 THROMBOCYTOPENIA 93 0.0011
402 PURPURA 8 0.0011
403 CYTOPENIA 7 0.0011
404 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0011
405 NECROSIS 5 0.0011
406 GASTROINTESTINAL ULCER 2 0.0011
407 BLOOD CREATININE INCREASED 57 0.0011
408 ELECTROLYTE IMBALANCE 9 0.0011
409 MYELOSUPPRESSION 8 0.0011
410 CARDIAC FAILURE 66 0.0011
411 APLASIA 2 0.0011
412 ALANINE AMINOTRANSFERASE INCREASED 53 0.0011
413 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0011
414 WHITE BLOOD CELL COUNT INCREASED 33 0.0011
415 CARDIAC DYSFUNCTION 2 0.0011
416 RESPIRATORY ACIDOSIS 3 0.0011
417 BLOOD POTASSIUM ABNORMAL 2 0.0011
418 VIROLOGIC FAILURE 4 0.0011
419 CANDIDA INFECTION 12 0.0011
420 C-REACTIVE PROTEIN INCREASED 27 0.0011
421 BRONCHOSPASM 12 0.0011
422 LOW BIRTH WEIGHT BABY 6 0.0010
423 OXYGEN SATURATION DECREASED 39 0.0010
424 CARDIAC FAILURE CHRONIC 3 0.0010
425 AORTIC ARTERIOSCLEROSIS 2 0.0010
426 PULSE ABSENT 4 0.0010
427 HYPERTHERMIA 6 0.0010
428 APLASTIC ANAEMIA 4 0.0010
429 ASPIRATION 8 0.0010
430 CYSTITIS HAEMORRHAGIC 3 0.0010
431 TRICUSPID VALVE INCOMPETENCE 6 0.0010
432 LEUKOENCEPHALOPATHY 3 0.0010
433 ANAPHYLACTIC SHOCK 18 0.0010
434 HYPONATRAEMIA 43 0.0010
435 CARDIO-RESPIRATORY ARREST 34 0.0010
436 PNEUMONIA ASPIRATION 18 0.0010
437 CONJUNCTIVAL HAEMORRHAGE 3 0.0010
438 VASCULITIS 8 0.0010
439 HYPOTENSION 146 0.0010
440 DRUG ERUPTION 12 0.0010
441 BLOOD PRESSURE DECREASED 48 0.0010
442 PNEUMOTHORAX 11 0.0009
443 VENOUS THROMBOSIS 3 0.0009
444 HEPATITIS TOXIC 2 0.0009
445 BLOOD SODIUM INCREASED 2 0.0009
446 DERMATITIS ALLERGIC 8 0.0009
447 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0009
448 DIABETIC NEUROPATHY 4 0.0009
449 PNEUMONITIS 17 0.0009
450 PLATELET COUNT DECREASED 73 0.0009
451 JAUNDICE 21 0.0009
452 DECUBITUS ULCER 6 0.0009
453 NEPHROPATHY TOXIC 7 0.0009
454 COVID-19 PNEUMONIA 6 0.0009
455 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0009
456 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0009
457 ABDOMINAL ABSCESS 3 0.0009
458 BLOOD CHLORIDE DECREASED 2 0.0009
459 HYPERPARATHYROIDISM SECONDARY 2 0.0009
460 HYPOTHERMIA 7 0.0009
461 BLOOD CREATINE INCREASED 3 0.0009
462 CARDIAC ARREST 59 0.0009
463 ECCHYMOSIS 5 0.0009
464 PERICARDIAL EFFUSION 15 0.0009
465 HAEMOGLOBIN DECREASED 71 0.0009
466 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0009
467 MITRAL VALVE INCOMPETENCE 8 0.0009
468 PERIPHERAL VASCULAR DISORDER 4 0.0009
469 LEUKOPENIA 33 0.0009
470 HYDRONEPHROSIS 5 0.0009
471 AORTIC VALVE INCOMPETENCE 3 0.0009
472 METABOLIC DISORDER 4 0.0009
473 BONE MARROW FAILURE 16 0.0009
474 CUSHINGOID 2 0.0009
475 VENTRICULAR TACHYCARDIA 11 0.0009
476 LEFT VENTRICULAR HYPERTROPHY 3 0.0009
477 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0009
478 GROWTH RETARDATION 2 0.0009
479 CARDIAC VALVE DISEASE 4 0.0009
480 BRADYCARDIA 36 0.0009
481 MENTAL STATUS CHANGES 19 0.0009
482 POST PROCEDURAL COMPLICATION 13 0.0009
483 ANAPHYLACTIC REACTION 32 0.0008
484 DISABILITY 12 0.0008
485 POST PROCEDURAL HAEMORRHAGE 8 0.0008
486 CARDIOMEGALY 9 0.0008
487 HEPATITIS FULMINANT 2 0.0008
488 PRODUCT LABEL CONFUSION 3 0.0008
489 LIVER DISORDER 27 0.0008
490 BRAIN DEATH 2 0.0008
491 PULMONARY HYPERTENSION 14 0.0008
492 HAEMOLYSIS 5 0.0008
493 HYPOVOLAEMIC SHOCK 3 0.0008
494 GASTRIC ULCER HAEMORRHAGE 4 0.0008
495 CARDIAC TAMPONADE 3 0.0008
496 HEPATIC CIRRHOSIS 11 0.0008
497 BLOOD LACTIC ACID INCREASED 3 0.0008
498 BILE DUCT STONE 2 0.0008
499 MYASTHENIA GRAVIS 3 0.0008
500 PATHOGEN RESISTANCE 5 0.0008
501 HYPERAMMONAEMIA 3 0.0008
502 LOCALISED OEDEMA 3 0.0008
503 NEUTROPHIL COUNT DECREASED 22 0.0008
504 DRUG TOXICITY 11 0.0008
505 POLYP 4 0.0008
506 DEFORMITY 6 0.0008
507 HEPATIC FIBROSIS 2 0.0008
508 DEVICE RELATED INFECTION 10 0.0008
509 CREPITATIONS 2 0.0008
510 STREPTOCOCCAL INFECTION 3 0.0008
511 ACUTE MYELOID LEUKAEMIA 9 0.0008
512 PYELONEPHRITIS 5 0.0008
513 MOTOR DYSFUNCTION 6 0.0008
514 BLOOD PHOSPHORUS DECREASED 2 0.0008
515 ENDOCARDITIS 3 0.0008
516 APNOEA 5 0.0008
517 TACHYCARDIA 52 0.0008
518 ATRIAL FLUTTER 5 0.0008
519 OEDEMA 31 0.0008
520 DIVERTICULUM 5 0.0008
521 REFUSAL OF TREATMENT BY PATIENT 4 0.0008
522 LUNG INFECTION 12 0.0008
523 LEFT VENTRICULAR FAILURE 2 0.0008
524 ANXIETY DISORDER 2 0.0008
525 SERUM FERRITIN INCREASED 3 0.0008
526 INTERNATIONAL NORMALISED RATIO INCREASED 20 0.0008
527 EMBOLISM 5 0.0008
528 ANAEMIA 111 0.0008
529 HYPERCALCAEMIA 7 0.0008
530 PERIORBITAL OEDEMA 3 0.0008
531 WOUND INFECTION 5 0.0008
532 ANGIONEUROTIC OEDEMA 2 0.0008
533 PETECHIAE 6 0.0007
534 TRANSFUSION 6 0.0007
535 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0007
536 PSYCHOLOGICAL TRAUMA 6 0.0007
537 PERITONITIS BACTERIAL 6 0.0007
538 STILLBIRTH 3 0.0007
539 B-CELL LYMPHOMA 2 0.0007
540 NEOPLASM PROGRESSION 18 0.0007
541 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
542 JAUNDICE CHOLESTATIC 2 0.0007
543 STAPHYLOCOCCAL INFECTION 19 0.0007
544 PNEUMONIA BACTERIAL 4 0.0007
545 HYDROCEPHALUS 3 0.0007
546 DYSPHORIA 3 0.0007
547 INTESTINAL PERFORATION 6 0.0007
548 MYDRIASIS 7 0.0007
549 ASPERGILLUS INFECTION 3 0.0007
550 HAEMORRHAGE SUBCUTANEOUS 2 0.0007
551 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0007
552 PROTEINURIA 9 0.0007
553 PYREXIA 178 0.0007
554 MELAENA 12 0.0007
555 CEREBRAL ISCHAEMIA 3 0.0007
556 AZOTAEMIA 2 0.0007
557 CAROTID ARTERY STENOSIS 2 0.0007
558 ATRIOVENTRICULAR BLOCK 4 0.0007
559 THERAPY NON-RESPONDER 17 0.0007
560 HYPERGLYCAEMIA 19 0.0007
561 RED BLOOD CELL COUNT DECREASED 14 0.0007
562 LIPASE INCREASED 4 0.0007
563 ALTERED STATE OF CONSCIOUSNESS 10 0.0007
564 UNRESPONSIVE TO STIMULI 13 0.0007
565 CARDIAC FAILURE ACUTE 3 0.0007
566 ABSCESS LIMB 2 0.0007
567 ANGIOPATHY 3 0.0006
568 HAEMATURIA 18 0.0006
569 PAIN 302 0.0006
570 CHOLESTASIS 9 0.0006
571 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0006
572 GASTROINTESTINAL PERFORATION 2 0.0006
573 INTERSTITIAL LUNG DISEASE 22 0.0006
574 HEPATOTOXICITY 10 0.0006
575 LIVER FUNCTION TEST ABNORMAL 16 0.0006
576 LARYNGEAL OEDEMA 3 0.0006
577 PNEUMONIA 146 0.0006
578 METABOLIC ACIDOSIS 14 0.0006
579 MUCOSAL INFLAMMATION 12 0.0006
580 LIP OEDEMA 2 0.0006
581 DIVERTICULUM INTESTINAL 2 0.0006
582 ANAPHYLACTOID REACTION 2 0.0006
583 NERVOUS SYSTEM DISORDER 16 0.0006
584 TROPONIN INCREASED 3 0.0006
585 WHITE BLOOD CELL COUNT DECREASED 48 0.0006
586 JOINT RANGE OF MOTION DECREASED 5 0.0006
587 PROCEDURAL COMPLICATION 4 0.0006
588 PULMONARY CONGESTION 6 0.0006
589 PLEURISY 3 0.0006
590 PERITONITIS 10 0.0006
591 GASTROINTESTINAL HAEMORRHAGE 43 0.0006
592 SUBDURAL HAEMATOMA 7 0.0006
593 IMMOBILE 2 0.0006
594 SCAR 8 0.0006
595 HYPOPHOSPHATAEMIA 3 0.0006
596 GRANULOCYTOPENIA 3 0.0006
597 BREATH SOUNDS ABNORMAL 2 0.0006
598 ACUTE KIDNEY INJURY 62 0.0006
599 ATRIAL FIBRILLATION 43 0.0006
600 GUILLAIN-BARRE SYNDROME 2 0.0006
601 LEG AMPUTATION 2 0.0006
602 HYPOGAMMAGLOBULINAEMIA 2 0.0006
603 NO THERAPEUTIC RESPONSE 7 0.0006
604 SPINAL COMPRESSION FRACTURE 4 0.0006
605 ABNORMAL SENSATION IN EYE 2 0.0006
606 BLOOD POTASSIUM DECREASED 13 0.0006
607 ANAL INCONTINENCE 3 0.0006
608 INTERVERTEBRAL DISC DISORDER 2 0.0006
609 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0006
610 ANURIA 4 0.0006
611 ADRENAL INSUFFICIENCY 4 0.0006
612 HAEMOLYTIC ANAEMIA 4 0.0006
613 CONVULSION 32 0.0006
614 BLOOD TRIGLYCERIDES INCREASED 8 0.0006
615 VITAMIN D DEFICIENCY 4 0.0006
616 SMALL INTESTINAL OBSTRUCTION 5 0.0005
617 OEDEMA PERIPHERAL 55 0.0005
618 SINUS TACHYCARDIA 6 0.0005
619 GRAND MAL CONVULSION 5 0.0005
620 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
621 LUNG DISORDER 19 0.0005
622 THERMAL BURN 3 0.0005
623 INFUSION RELATED REACTION 23 0.0005
624 TUBERCULOSIS 5 0.0005
625 ARTERIOSCLEROSIS 4 0.0005
626 ESCHERICHIA INFECTION 3 0.0005
627 ISCHAEMIA 2 0.0005
628 TOXIC SKIN ERUPTION 4 0.0005
629 NEUTROPENIA 48 0.0005
630 HAEMATOMA 11 0.0005
631 COMA 19 0.0005
632 FACIAL PARALYSIS 3 0.0005
633 DEPRESSION 95 0.0005
634 HEPATOCELLULAR CARCINOMA 3 0.0005
635 TUBULOINTERSTITIAL NEPHRITIS 7 0.0005
636 HAEMORRHOIDAL HAEMORRHAGE 2 0.0005
637 LYMPHOPENIA 5 0.0005
638 HAEMOPTYSIS 11 0.0005
639 HYPERLIPIDAEMIA 5 0.0005
640 RESPIRATORY ARREST 12 0.0005
641 ACUTE MYOCARDIAL INFARCTION 12 0.0005
642 MALIGNANT NEOPLASM PROGRESSION 34 0.0005
643 ABDOMINAL DISTENSION 37 0.0005
644 FULL BLOOD COUNT ABNORMAL 2 0.0005
645 AMMONIA INCREASED 2 0.0005
646 GINGIVITIS 2 0.0005
647 ARRHYTHMIA 18 0.0005
648 AORTIC ANEURYSM 3 0.0005
649 GASTROINTESTINAL INFECTION 3 0.0005
650 DISEASE PROGRESSION 37 0.0005
651 HIATUS HERNIA 5 0.0005
652 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0005
653 RENAL CYST 3 0.0005
654 DERMATITIS ACNEIFORM 2 0.0005
655 MOUTH ULCERATION 7 0.0005
656 CEREBRAL INFARCTION 9 0.0005
657 ENTERITIS 2 0.0005
658 POOR QUALITY DRUG ADMINISTERED 3 0.0005
659 CEREBRAL HAEMORRHAGE 13 0.0005
660 HAEMORRHOIDS 7 0.0005
661 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0005
662 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0005
663 PHOTOPHOBIA 6 0.0005
664 RASH ERYTHEMATOUS 14 0.0005
665 INTESTINAL HAEMORRHAGE 2 0.0005
666 INSURANCE ISSUE 2 0.0005
667 RESPIRATORY RATE INCREASED 3 0.0004
668 BLOOD CALCIUM DECREASED 4 0.0004
669 MYOPATHY 3 0.0004
670 MYOCARDITIS 3 0.0004
671 GENERAL PHYSICAL HEALTH DETERIORATION 34 0.0004
672 HYPERAESTHESIA 3 0.0004
673 HEPATITIS CHOLESTATIC 2 0.0004
674 RESPIRATORY DISORDER 10 0.0004
675 HAEMORRHAGE 34 0.0004
676 SKIN HYPERPIGMENTATION 3 0.0004
677 CROHN'S DISEASE 3 0.0004
678 DERMATITIS EXFOLIATIVE 2 0.0004
679 BODY TEMPERATURE INCREASED 7 0.0004
680 EJECTION FRACTION DECREASED 5 0.0004
681 SARS-COV-2 TEST POSITIVE 3 0.0004
682 CEREBROVASCULAR ACCIDENT 59 0.0004
683 LYMPHOMA 5 0.0004
684 PREMATURE BABY 10 0.0004
685 PULMONARY ARTERIAL HYPERTENSION 5 0.0004
686 PREMATURE DELIVERY 5 0.0004
687 INTESTINAL OBSTRUCTION 11 0.0004
688 RESPIRATORY DEPRESSION 4 0.0004
689 EPILEPSY 9 0.0004
690 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0004
691 DEEP VEIN THROMBOSIS 23 0.0004
692 AUTOIMMUNE HEPATITIS 2 0.0004
693 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0004
694 ACUTE HEPATIC FAILURE 4 0.0004
695 ENCEPHALITIS 2 0.0004
696 PRODUCTIVE COUGH 13 0.0004
697 FUNGAL INFECTION 10 0.0004
698 HYPOTHYROIDISM 9 0.0004
699 OVARIAN CANCER 3 0.0004
700 DELIRIUM 10 0.0004
701 CARDIAC FAILURE CONGESTIVE 29 0.0004
702 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0004
703 BRAIN INJURY 3 0.0004
704 BLOOD URINE PRESENT 6 0.0004
705 BLOOD POTASSIUM INCREASED 5 0.0004
706 HAEMATEMESIS 8 0.0004
707 SINUS BRADYCARDIA 3 0.0004
708 GASTRIC ULCER 6 0.0004
709 URINARY INCONTINENCE 9 0.0004
710 CHROMATURIA 7 0.0004
711 CHOLELITHIASIS 10 0.0004
712 ANOREXIA 5 0.0004
713 SUBARACHNOID HAEMORRHAGE 3 0.0004
714 SECRETION DISCHARGE 3 0.0004
715 LYMPHADENOPATHY 10 0.0004
716 LARGE INTESTINE POLYP 2 0.0004
717 FACE OEDEMA 5 0.0004
718 EMPHYSEMA 3 0.0004
719 INCONTINENCE 3 0.0004
720 NERVOUSNESS 16 0.0004
721 DUODENAL ULCER 2 0.0004
722 VENTRICULAR EXTRASYSTOLES 3 0.0004
723 BLINDNESS TRANSIENT 2 0.0004
724 RESTLESSNESS 10 0.0004
725 BLOOD SODIUM DECREASED 5 0.0004
726 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0003
727 BLISTER 14 0.0003
728 ECZEMA 7 0.0003
729 PULMONARY EMBOLISM 27 0.0003
730 KETOACIDOSIS 2 0.0003
731 DIABETES MELLITUS 21 0.0003
732 HYPERTENSIVE CRISIS 3 0.0003
733 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
734 GASTRITIS 7 0.0003
735 RHABDOMYOLYSIS 11 0.0003
736 CARDIOMYOPATHY 4 0.0003
737 ELECTROCARDIOGRAM QT PROLONGED 9 0.0003
738 HEARING IMPAIRED 2 0.0003
739 CELLULITIS 13 0.0003
740 CHILLS 29 0.0003
741 DEHYDRATION 34 0.0003
742 RECTAL HAEMORRHAGE 11 0.0003
743 HYPERCHOLESTEROLAEMIA 2 0.0003
744 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
745 AGRANULOCYTOSIS 4 0.0003
746 URINARY TRACT INFECTION 39 0.0003
747 PANCREATITIS 13 0.0003
748 DYSURIA 9 0.0003
749 RASH MACULO-PAPULAR 5 0.0003
750 PALLOR 6 0.0003
751 HYPOGLYCAEMIA 12 0.0003
752 CHEST DISCOMFORT 23 0.0003
753 DRUG LEVEL DECREASED 2 0.0003
754 MEDICATION ERROR 13 0.0003
755 MENTAL DISORDER 10 0.0003
756 CORONARY ARTERY DISEASE 8 0.0003
757 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0003
758 HYPERTENSION 46 0.0003
759 HAEMATOCHEZIA 11 0.0003
760 HYPERTHYROIDISM 3 0.0003
761 INFECTION 29 0.0003
762 HEMIPARESIS 4 0.0003
763 DEVICE FAILURE 3 0.0003
764 LEUKAEMIA 2 0.0003
765 FLANK PAIN 2 0.0003
766 URINARY RETENTION 7 0.0003
767 NEPHROLITHIASIS 9 0.0003
768 LABORATORY TEST ABNORMAL 6 0.0003
769 STOMATITIS 12 0.0003
770 ECONOMIC PROBLEM 4 0.0003
771 LACTIC ACIDOSIS 6 0.0003
772 ERYTHEMA MULTIFORME 2 0.0003
773 DYSPNOEA 116 0.0003
774 CARDIAC MURMUR 2 0.0003
775 PARALYSIS 3 0.0003
776 CARDIOVASCULAR DISORDER 6 0.0003
777 PRODUCT USE IN UNAPPROVED INDICATION 37 0.0003
778 SKIN DISORDER 6 0.0003
779 ABDOMINAL PAIN 45 0.0003
780 SLEEP APNOEA SYNDROME 4 0.0003
781 FISTULA 2 0.0003
782 ADVERSE EVENT 18 0.0003
783 CONJUNCTIVITIS 3 0.0003
784 RENAL DISORDER 9 0.0003
785 CENTRAL NERVOUS SYSTEM LESION 3 0.0003
786 ANGINA PECTORIS 6 0.0003
787 DISORIENTATION 8 0.0002
788 HYPOTONIA 2 0.0002
789 CARDIAC DISORDER 18 0.0002
790 DYSPHAGIA 17 0.0002
791 PANCREATITIS ACUTE 4 0.0002
792 DEATH 149 0.0002
793 AGITATION 14 0.0002
794 HEPATIC ENZYME INCREASED 11 0.0002
795 ACCIDENTAL OVERDOSE 6 0.0002
796 ERYTHEMA 36 0.0002
797 TRANSAMINASES INCREASED 4 0.0002
798 LOSS OF CONSCIOUSNESS 23 0.0002
799 FLUID RETENTION 9 0.0002
800 RESPIRATORY TRACT INFECTION 4 0.0002
801 CONDITION AGGRAVATED 44 0.0002
802 LIVER INJURY 3 0.0002
803 DIARRHOEA 102 0.0002
804 CONFUSIONAL STATE 28 0.0002
805 POLLAKIURIA 7 0.0002
806 MYOCARDIAL INFARCTION 34 0.0002
807 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
808 TREATMENT NONCOMPLIANCE 8 0.0002
809 CHOLECYSTITIS 2 0.0002
810 INJECTION SITE DISCOLOURATION 2 0.0002
811 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
812 DIABETIC KETOACIDOSIS 4 0.0002
813 DERMATITIS 3 0.0002
814 HEPATIC STEATOSIS 3 0.0002
815 LACERATION 2 0.0002
816 IMMUNE SYSTEM DISORDER 2 0.0002
817 KIDNEY INFECTION 3 0.0002
818 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
819 EPISTAXIS 12 0.0002
820 EXPOSURE DURING PREGNANCY 9 0.0002
821 HEPATITIS 4 0.0002
822 JOINT STIFFNESS 4 0.0002
823 GASTRIC HAEMORRHAGE 2 0.0002
824 COUGH 40 0.0002
825 SKIN ULCER 4 0.0002
826 BLINDNESS 6 0.0002
827 RASH MACULAR 5 0.0002
828 FOETAL EXPOSURE DURING PREGNANCY 12 0.0002
829 THERAPY INTERRUPTED 4 0.0002
830 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
831 EMOTIONAL DISORDER 5 0.0002
832 COLITIS 5 0.0002
833 SKIN DISCOLOURATION 7 0.0002
834 ASTHENIA 56 0.0002
835 EYELID OEDEMA 2 0.0002
836 URTICARIA 23 0.0002
837 END STAGE RENAL DISEASE 3 0.0002
838 BRONCHITIS 11 0.0002
839 GENITAL HAEMORRHAGE 2 0.0002
840 BLINDNESS UNILATERAL 2 0.0002
841 HALLUCINATION 10 0.0002
842 MUSCULAR WEAKNESS 16 0.0002
843 THERAPEUTIC RESPONSE DECREASED 8 0.0002
844 EATING DISORDER 3 0.0002
845 TREMOR 24 0.0002
846 TREATMENT FAILURE 10 0.0002
847 HYPERSENSITIVITY 25 0.0002
848 FAECES DISCOLOURED 3 0.0002
849 LIMB DISCOMFORT 4 0.0002
850 HEART RATE INCREASED 13 0.0002
851 WHEEZING 7 0.0002
852 ABNORMAL BEHAVIOUR 6 0.0002
853 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
854 SPEECH DISORDER 7 0.0002
855 DRUG-INDUCED LIVER INJURY 3 0.0002
856 APHASIA 4 0.0002
857 RASH PAPULAR 3 0.0002
858 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0002
859 SYNCOPE 13 0.0002
860 MUSCLE TWITCHING 3 0.0002
861 PRESYNCOPE 3 0.0002
862 DECREASED APPETITE 27 0.0002
863 HYPOPHAGIA 3 0.0002
864 HERPES ZOSTER 7 0.0002
865 CYSTITIS 4 0.0002
866 VOMITING 55 0.0002
867 BLOOD GLUCOSE INCREASED 24 0.0002
868 COLITIS ULCERATIVE 4 0.0002
869 BONE PAIN 7 0.0002
870 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
871 PROCEDURAL PAIN 3 0.0002
872 HEART RATE DECREASED 4 0.0002
873 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
874 DRUG INTERACTION 18 0.0001
875 PAIN OF SKIN 3 0.0001
876 DISEASE RECURRENCE 3 0.0001
877 SKIN EXFOLIATION 8 0.0001
878 CONSTIPATION 21 0.0001
879 PRURITUS GENERALISED 3 0.0001
880 DYSARTHRIA 4 0.0001
881 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
882 OFF LABEL USE 66 0.0001
883 GLOSSODYNIA 2 0.0001
884 DRUG DISPENSING ERROR 2 0.0001
885 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
886 WEIGHT INCREASED 21 0.0001
887 DYSKINESIA 4 0.0001
888 CONTUSION 9 0.0001
889 RASH 38 0.0001
890 NEUROPATHY PERIPHERAL 8 0.0001
891 NECK PAIN 5 0.0001
892 MOBILITY DECREASED 6 0.0001
893 DYSPNOEA EXERTIONAL 3 0.0001
894 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
895 DRUG RESISTANCE 2 0.0001
896 VAGINAL HAEMORRHAGE 4 0.0001
897 HYPERHIDROSIS 11 0.0001
898 PRURITUS 27 0.0001
899 BLOOD PRESSURE FLUCTUATION 2 0.0001
900 LIMB INJURY 2 0.0001
901 DEVICE BREAKAGE 2 0.0001
902 MEMORY IMPAIRMENT 11 0.0001
903 CHRONIC KIDNEY DISEASE 7 0.0001
904 NAUSEA 62 0.0001
905 SEIZURE 8 0.0001
906 DEAFNESS 2 0.0001
907 SWELLING 7 0.0001
908 LACRIMATION INCREASED 2 0.0001
909 SWELLING FACE 5 0.0001
910 DRY SKIN 9 0.0001
911 INJECTION SITE RASH 2 0.0001
912 DIVERTICULITIS 2 0.0001
913 ILL-DEFINED DISORDER 3 0.0001
914 BACK PAIN 17 0.0001
915 GASTRIC CANCER 2 0.0001
916 BLOOD PRESSURE INCREASED 11 0.0001
917 CHEST PAIN 14 0.0001
918 AMNESIA 5 0.0001
919 FLUSHING 8 0.0001
920 GASTRIC DISORDER 3 0.0001
921 THROAT IRRITATION 3 0.0001
922 FEELING COLD 2 0.0001
923 DYSPHONIA 4 0.0001
924 BURNING SENSATION 5 0.0001
925 PAIN IN EXTREMITY 21 0.0001
926 INFLAMMATION 3 0.0001
927 HYPOAESTHESIA 10 0.0001
928 BLOOD CHOLESTEROL INCREASED 3 0.0001
929 WEIGHT DECREASED 18 0.0001
930 EYE IRRITATION 3 0.0001
931 DRUG INEFFECTIVE 81 0.0001
932 IMPAIRED HEALING 2 0.0001
933 TOXICITY TO VARIOUS AGENTS 10 0.0001
934 NEOPLASM MALIGNANT 4 0.0001
935 DYSPEPSIA 6 0.0001
936 PARAESTHESIA 10 0.0001
937 MALAISE 28 0.0001
938 SURGERY 3 0.0001
939 THROMBOSIS 5 0.0001
940 SOMNOLENCE 12 0.0001
941 MUSCULOSKELETAL STIFFNESS 5 0.0001
942 DISCOMFORT 3 0.0001
943 BALANCE DISORDER 5 0.0001
944 COVID-19 5 0.0001
945 AGGRESSION 3 0.0001
946 ANGER 2 0.0001
947 ASTHMA 5 0.0001
948 FATIGUE 38 0.0001
949 INFLUENZA 5 0.0001
950 PERIPHERAL SWELLING 7 0.0001
951 LETHARGY 3 0.0001
952 NO ADVERSE EVENT 7 0.0001
953 FEELING HOT 3 0.0001
954 DRUG ADMINISTRATION ERROR 2 0.0001
955 MUSCULOSKELETAL PAIN 3 0.0001
956 FALL 16 0.0001
957 SLEEP DISORDER 3 0.0001
958 OVERDOSE 10 0.0001
959 ABDOMINAL PAIN UPPER 9 0.0001
960 VISUAL IMPAIRMENT 5 0.0001
961 COGNITIVE DISORDER 2 0.0001
962 PALPITATIONS 5 0.0001
963 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
964 SINUSITIS 4 0.0001
965 INSOMNIA 11 0.0001
966 ARTHRITIS 3 0.0001
967 DRUG HYPERSENSITIVITY 8 0.0001
968 BLOOD GLUCOSE DECREASED 2 0.0001
969 HEADACHE 24 0.0001
970 DIZZINESS 19 0.0001
971 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0001
972 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
973 FLATULENCE 2 0.0000
974 GAIT DISTURBANCE 7 0.0000
975 FEELING ABNORMAL 9 0.0000
976 OROPHARYNGEAL PAIN 3 0.0000
977 DRUG INTOLERANCE 3 0.0000
978 MUSCLE SPASMS 6 0.0000
979 INJECTION SITE PRURITUS 2 0.0000
980 NASOPHARYNGITIS 5 0.0000
981 PRODUCT USE ISSUE 5 0.0000
982 GASTROINTESTINAL DISORDER 2 0.0000
983 INJECTION SITE HAEMORRHAGE 2 0.0000
984 DYSGEUSIA 2 0.0000
985 ADVERSE DRUG REACTION 2 0.0000
986 PRODUCT QUALITY ISSUE 4 0.0000
987 DRY MOUTH 2 0.0000
988 ABDOMINAL DISCOMFORT 4 0.0000
989 ACNE 2 0.0000
990 HOSPITALISATION 3 0.0000
991 MYALGIA 4 0.0000
992 PRODUCT DOSE OMISSION ISSUE 3 0.0000
993 INCORRECT DOSE ADMINISTERED 4 0.0000
994 INFLUENZA LIKE ILLNESS 2 0.0000
995 ALOPECIA 4 0.0000
996 INJECTION SITE ERYTHEMA 2 0.0000
997 ARTHRALGIA 4 0.0000
998 INJECTION SITE PAIN 2 0.0000